Mindset Pharma Stock

0:21:33

How Mindset Pharma Dealt Partnership With Otsuka - TDR Exclusive

0:05:10

Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery

0:20:14

High Growth Stock to Watch | Cheap Biotech Stock | Stock News Today | Mindset Pharma | MSET

0:04:13

Mindset Pharma shares positive preclinical results on its two sets of psychedelic drug families

0:11:55

One Unique Biotech Stock To Watch Now? Mindset Pharma (OTC:MSSTF / CSE:MSET)

0:04:30

Mindset Pharma enters exclusive reseller deal with PharmAla for its pharmaceutical-grade psilocybin

0:06:59

Mindset Pharma and PharmAla partnership makes first medical grade psilocybin sale in Australia

0:12:55

Psychedelic Stocks in Focus | Business Update: James Lanthier, CEO of Mindset Pharma

0:10:53

Mindset Pharma positioned for strong future

0:06:14

Management of Mindset Pharma Educates us on the Basics of Psychedelic Patents!!!

0:17:55

Mindset Pharma: Shareholder Value in Psychedelics

0:21:01

Mindset CEO Reveals His Strategy - Trade To Black #12

0:06:22

Mindset Pharma CEO says the firm's recent efforts in the psychedelic space are delivering

0:05:17

Mindset says new collab with Otsuka is 'first' Big Pharma and psychedelic partnership

0:04:16

Mindset Pharma to move forward with its psilocybin-based compound named MSP-1014

0:04:52

Mindset Pharma says licensing agreement with Cybin gives it multiple 'shots for the goal'

0:07:59

Mindset Pharma (OTC:MSSTF) Streetlight Equity Review

0:05:54

Mindset Pharma chooses pair of psychedelic drug candidates to move Family 2 program forward

0:00:30

Mindset Pharma Inc. (MSET:CSE)

0:04:50

Mindset Pharma and InterVivo release first joint data set focused on psilocybin

0:06:44

Mindset Pharma 'excited' by recent, positive findings on its DMT-inspired chemicals

0:00:43

Best Stocks to Invest in 2024?

0:13:53

The Future of Psychedelic Medicines with Mindset Pharma

0:07:25

Mindset Pharma Halftime Report 2022